Global in vitro diagnostics (ivd) market trends and future forecast (2009 – 2014)

2010 Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)

Publisher: Renub Research Published: September, 2010

Report Details Our new report “Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)” examines the commercial prospects for In Vitro Diagnostics (IVD) in the global healthcare market. The report provides market landscape, competitive landscape and market trends information on ten market categories including Molecular Diagnostics, Clinical Chemistry,

Hematology,

Immunoassay,

Point

of

Care

Testing,

Microbiology,

Histology/Cytology, Flow Cytometry, Blood Screening Typing, and Coagulation. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report reviews the competitive landscape in terms of mergers and acquisitions, licensing, pipeline products and new technology offerings.

The report also analyses past present and future forecast of USA, Japan, Europe, India, China and Taiwan IVD market.

The report has been researched at source globally and features latest available data covering: 

Ten IVD sub-segment past, present and future forecast market share



Six countries (USA, Japan, Europe, India, China, Taiwan) past, present, future prospects in the IVD market



Top eight companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) IVD market share in 2009



Top ten Merger & Acquisition deals in 2008 and 2009



Licensing by ten IVD players



Review of International In Vitro Diagnostics Regulations



Key drivers of growth in the global IVD market



Key challenges faces by IVD market in the coming years

Research Highlights 

Globally, In Vitro Diagnostics market will cross US$ 60 Billion by 2014



Point of Care Testing dominates the In Vitro Diagnostics market with more than 30% market share in 2009

© Renub Research

Page 2 of 10



Molecular Diagnostics is the fastest growing segment in the In Vitro Diagnostics market, its market share will reach approximately 18% by 2014



In 2009 Roche, Siemens and Abbott Diagnostics together controls 42% market share in In Vitro Diagnostics, Roche controls the highest market share



After Point of Care Testing, Immunoassay is the second largest market with a market of more than US$ 7 Billion in 2009



Europe with more than US$ 10 Billion is the second largest In Vitro Diagnostics Market in 2009



51 Mergers & Acquisitions taken place in 2008 compared to 84 deals in 2007



18 In-Licensing deals were announced in 2008 compared to 27 in 2007



By 2009 there were 12 countries with more than 10 Million people aged 60 or over



Third Wave Technologies (TWT) was acquired by Hologic to grow its existing women’s health and diagnostics business was the best deal in 2008



In 2009, Beckman Coulter acquired the diagnostic systems part of Olympus’s life sciences to broaden its clinical chemistry offering, especially in the ultra-high throughput setting.

Key Players Analyzed This section covers the key facts about the major players in In Vitro Diagnostics market. The key players analyzed in this section are – Roche, Sysmex, Biomerieux, OCD(J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens.

Data Sources Information and data in this report has been collected from various printable and nonprintable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations.

© Renub Research

Page 3 of 10

Table of Contents 1.

Executive Summary

2.

Global In Vitro Diagnostics Market & Future Forecast

3.

4.

5.

2.1

Global – In Vitro Diagnostics Market Share & Future Forecast

2.2

Global IVD Market, Market Share by Company

In Vitro Diagnostics Market Segment – Past, Present & Future Forecast 3.1

Molecular Diagnostics

3.2

Clinical Chemistry

3.3

Hematology

3.4

Immunoassay

3.5

Point of Care Testing

3.6

Microbiology

3.7

Histology/Cytology

3.8

Flow Cytometry

3.9

Blood Screening Typing

3.10

Coagulation

Geographical Segmentation 4.1

USA – In Vitro Diagnostics Market

4.2

Japan – In Vitro Diagnostics Market

4.3

Europe – In Vitro Diagnostics Market

4.4

India – In Vitro Diagnostics Market

4.5

China – In Vitro Diagnostics Market

4.6

Taiwan – In Vitro Diagnostics Market

Merger & Acquisitions 5.1

Mergers & Acquisitions Deals in the IVD Sector, 2009

5.2

Number of All Mergers & Acquisitions Deals in the IVD Sector, (2004 - 2008)

5.3

Top Ten Mergers & Acquisitions Deals in the IVD Sector, 2008

© Renub Research

Page 4 of 10

5.4 6.

7.

Value of Disclosed Mergers & Acquisitions Deals in the IVD Sector, (2004 – 2008)

Licensing By Ten IVD Majors 6.1

Number of In-Licensing Deals Announced, (2004 – 2008)

6.2

Number of In-Licensing Deals announced in 2008 by Ten IVD Majors

6.3

Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies

6.4

In-Licensing Deals Announced in 2008 by Ten IVD Players

A Review of International IVD Regulations 7.1

GHTF and AHWP: Elements for a Regulatory System

7.2

More Emphasis on Environmental Topics

7.2.1 7.3

Auditing: A Tool for Improving Processes

7.3.1 7.4 8.

More Regulated Countries

Future Leadership and Outlook for the Next 15 Years

Key Drivers of Growth in Global IVD Market 8.1

Aging of the population

8.1.1

Population Aged 60 or Over: World and Development Regions, 1950 - 2050

8.1.2

Old-Age Dependency Ratio: Major Areas, 2009 and 2050

8.2

Personalized Medicine – The Future

8.3

Continued Expansion of Point Of Care Including Self Testing

8.3.1

Future of Point of Care Testing – The ‘Worried Well’

8.3.2

Theranostics – Companion Diagnostics

8.3.3

Hub and Spoke

8.3.4

Education

8.4 9.

Instructions for Use and Other Labeling

Pharmacogenetic Testing and New Types of Genetic Disease Screening Tests

Key Challenges In the Global In-Vitro Diagnostics Market 9.1

Regulatory and Reimbursement Issues

9.1.1 9.2

Coverage Policies

Manufacturing Obstacles in IVD Product Development

9.2.1

Rise in Point of Care (POC) Technologies

9.2.2

Avoiding Too Much, Too Soon

9.2.3

Closely Considering Materials and Environment

© Renub Research

Page 5 of 10

10.

Key Players in the Global IVD Market

10.1

Abbott Laboratories

10.2

Roche

10.3

biomerieux

10.4

Beckman Coulter

10.5

BD (Becton, Dickinson and Company)

10.6

Sysmex

10.7

Siemens

10.8

Ortho Clinical Diagnostics

Š Renub Research

Page 6 of 10

Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com

Format Report Title: Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1,200

US$ 1,300

US$ 1,300

US$ 1,700

For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/global-in-vitro-diagnostics-ivd-market-trends-and-futureforecast-2009---2014-31 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=31&pid=1105 To pay by Wire Transfer, please, fill in your contact details in the form below:

© Renub Research

Page 7 of 10

Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India

Contact Information First Name:

Last Name:

Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:

© Renub Research

Page 8 of 10

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor, C-86, Sector -10, Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

Š Renub Research

Page 9 of 10

Š Renub Research

Page 10 of 10